Wells Fargo’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
16,527
-25,972
-61% -$1.89M ﹤0.01% 3543
2025
Q4
$3.21M Buy
42,499
+20,509
+93% +$1.29M ﹤0.01% 3063
2025
Q3
$874K Buy
21,990
+5,137
+30% +$196K ﹤0.01% 3907
2025
Q2
$732K Sell
16,853
-1,251
-7% -$47.6K ﹤0.01% 3892
2025
Q1
$676K Buy
18,104
+399
+2% +$15.4K ﹤0.01% 3883
2024
Q4
$802K Sell
17,705
-80,585
-82% -$4.11M ﹤0.01% 3866
2024
Q3
$5.77M Buy
98,290
+86,710
+749% +$4.15M ﹤0.01% 2243
2024
Q2
$456K Sell
11,580
-1,848
-14% -$89.7K ﹤0.01% 3970
2024
Q1
$892K Buy
13,428
+7,570
+129% +$331K ﹤0.01% 3536
2023
Q4
$164K Buy
5,858
+1,455
+33% +$29.2K ﹤0.01% 4594
2023
Q3
$93.8K Buy
+4,403
New +$97K ﹤0.01% 4816

Other funds holding APGE